Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Pocard

Showing results (161-170 of 277) with videos related to

Pageof 28
Sort By:
Annals of Surgical Oncology|September 27, 2007
Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failureValérie Boige, David Malka, Dominique Elias, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
ERCC1 codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancerJérôme Viguier, Valérie Boige, Catherine Miquel, et al.
Neoplasia (New York, N.Y.)|November 5, 2020
Injured tissues favor cancer cell implantation via fibrin deposits on scar zonesIman Al Dybiat, Shahsoltan Mirshahi, Meriem Belalou, et al.
Current Oncology Reports|February 11, 2016
New Therapeutic Opportunities Based on DNA Mismatch Repair and BRAF Status in Metastatic Colorectal CancerRomain Cohen, Magali Svrcek, Chantal Dreyer, et al.
ACS Nano|February 2, 2021
Tumor-Selective Immune-Active Mild Hyperthermia Associated with Chemotherapy in Colon Peritoneal Metastasis by Photoactivation of Fluorouracil-Gold Nanoparticle ComplexesVladimir Mulens-Arias, Alba Nicolás-Boluda, Amandine Pinto, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 17, 2026
Thromboprophylaxis, pain and organization: How do expert centers manage PIPAC's perioperative care? An international surveyJade Fawaz, Martin Hübner, Anne-Cécile Ezanno, et al.
Oncology Reports|June 18, 2015
Activated protein C upregulates ovarian cancer cell migration and promotes unclottability of the cancer cell microenvironmentHamda Althawadi, Halema Alfarsi, Samaher Besbes, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 2, 2026
First preclinical evaluation of a thermogel delivering mitomycin C: sustained local release with preserved surgical safety in a large animal modelChristian Mouawad, Agathe Thouvenin, Paul Rozenbaum, et al.
Diseases of the Colon and Rectum|October 18, 2005
Quality of life of patients operated on for low rectal cancer: impact of the type of surgery and patients' characteristicsLucas Sideris, Franck Zenasni, Dewi Vernerey, et al.
Pleura and Peritoneum|March 27, 2019
Intraperitoneal aerosolization of albumin-stabilized paclitaxel nanoparticles (Abraxane™) for peritoneal carcinomatosis - a phase I first-in-human studyLeen Van De Sande, Martin Graversen, Martin Hubner, et al.
Pageof 28

Showing results (161-170 of 277) with videos related to

Sort By:
Pageof 28
Annals of Surgical Oncology|September 27, 2007
Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failureValérie Boige, David Malka, Dominique Elias, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
ERCC1 codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancerJérôme Viguier, Valérie Boige, Catherine Miquel, et al.
Neoplasia (New York, N.Y.)|November 5, 2020
Injured tissues favor cancer cell implantation via fibrin deposits on scar zonesIman Al Dybiat, Shahsoltan Mirshahi, Meriem Belalou, et al.
Current Oncology Reports|February 11, 2016
New Therapeutic Opportunities Based on DNA Mismatch Repair and BRAF Status in Metastatic Colorectal CancerRomain Cohen, Magali Svrcek, Chantal Dreyer, et al.
ACS Nano|February 2, 2021
Tumor-Selective Immune-Active Mild Hyperthermia Associated with Chemotherapy in Colon Peritoneal Metastasis by Photoactivation of Fluorouracil-Gold Nanoparticle ComplexesVladimir Mulens-Arias, Alba Nicolás-Boluda, Amandine Pinto, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 17, 2026
Thromboprophylaxis, pain and organization: How do expert centers manage PIPAC's perioperative care? An international surveyJade Fawaz, Martin Hübner, Anne-Cécile Ezanno, et al.
Oncology Reports|June 18, 2015
Activated protein C upregulates ovarian cancer cell migration and promotes unclottability of the cancer cell microenvironmentHamda Althawadi, Halema Alfarsi, Samaher Besbes, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 2, 2026
First preclinical evaluation of a thermogel delivering mitomycin C: sustained local release with preserved surgical safety in a large animal modelChristian Mouawad, Agathe Thouvenin, Paul Rozenbaum, et al.
Diseases of the Colon and Rectum|October 18, 2005
Quality of life of patients operated on for low rectal cancer: impact of the type of surgery and patients' characteristicsLucas Sideris, Franck Zenasni, Dewi Vernerey, et al.
Pleura and Peritoneum|March 27, 2019
Intraperitoneal aerosolization of albumin-stabilized paclitaxel nanoparticles (Abraxane™) for peritoneal carcinomatosis - a phase I first-in-human studyLeen Van De Sande, Martin Graversen, Martin Hubner, et al.
Pageof 28